Novo Nordisk (NVO)
Novo Nordisk Market Cap: 78.76B
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
NVO Market Cap Rankings
| Overall | 98th percentile | 53 of 4663 |
| Sector | 98th percentile | 8 of 525 in Healthcare |
| Industry | 97th percentile | 1 of 42 in Drug Manufacturers - Other |
NVO Market Cap Range, Past 5 Years
| Minimum | 30.42B | Mar 2009 |
| Maximum | 80.45B | Mar 2012 |
| Average | 51.67B |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these NVO related companies
NVO News
Any reason for the huge surge in volume in the last two trading days in shares of $NVO - Around 6x normal.
about 8 days ago by sld1986
about 8 days ago by sld1986
SINA Corporation, Darden Restaurants Included in Stocks Up on High Volume Wednesday
May 16, 12:35PM Fox Business
May 16, 12:35PM Fox Business
$NVO May have to buy this again now that austerity is dead- Vive le diabetes!
about 22 days ago by jjshaka
about 22 days ago by jjshaka
$NVO is consistently trying to breach the $150/share barrier over the past 5trading days.
about 27 days ago by spiff_spaceman
about 27 days ago by spiff_spaceman
$NVO Novo Nordisk earnings disappoint, market share down in China, but new anti-obesity wonder drug Victoza sells well. http://stks.co/3XtR
about 34 days ago by tradingfloorcom
about 34 days ago by tradingfloorcom
$AMLN Advisory group request FDA remove Victoza ($NVO) from market.
about 41 days ago by jackofalltrade
about 41 days ago by jackofalltrade
Still like my $YUM as KFC's dot China. Don't forget the Diabetes stocks $NVO New high for Yum!
about 43 days ago by billgunderson
about 43 days ago by billgunderson
@adelchibattaglini still waiting for a larger pullback, you can track $NVO listed on the Danish stock exchange here http://stks.co/3IjJ
about 50 days ago by sld1986
about 50 days ago by sld1986
@sld1986 hi, do you think it's time today (144.35) to open a position in $NVO or the pullback is still not significant?
about 50 days ago by adelchibattaglini
about 50 days ago by adelchibattaglini
Two European stocks I am looking to buy on any significant pull-back are $NVO $DEO
about 50 days ago by sld1986
about 50 days ago by sld1986
http://stks.co/3Fk1 - excitement and growth in drug stocks $NVO $ARNA $VVUS $AMLN $OREX $VRTX recommended article. $NVO been my top pick
about 54 days ago by sld1986
about 54 days ago by sld1986
RT @Partridge $NVO awesomness - my only healthcare position from far far left
Feb. 28 at 9:19 AM -- the world is addicted to fat
about 57 days ago by Partridge
about 57 days ago by Partridge
7 High Profitable Healthcare Dividend Stocks With Fantastic Yields + http://stks.co/2dw4 + $PDLI $AZN $PMD $GSK $BMY $NVO $SHPGY
about 90 days ago by DividendYield
about 90 days ago by DividendYield
$NVO moving average looks good as well as pivot points... could possibly go through R2
about 94 days ago by soccerben
about 94 days ago by soccerben
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| NVO | 135.80 | -2.83 | -2.04% | 80.41B |
| NVMI | 7.00 | +0.00 | +0.00% | 183.89M |
| NVLS | 42.29 | -1.21 | -2.78% | 3.080B |
| NVJ | 15.54 | -0.05 | -0.30% | |
| NVEC | 51.74 | -1.01 | -1.91% | 254.26M |
| NVE | 17.09 | -0.16 | -0.93% | 4.071B |
| NVDA | 12.54 | -0.18 | -1.42% | 7.857B |
| NVAX | 1.235 | -0.04 | -3.52% | 155.61M |
| NPK | 66.07 | -0.36 | -0.54% | 457.04M |
| NPF | 15.05 | -0.01 | -0.07% |
